HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A meta-analysis of low dose aspirin for the prevention of intrauterine growth retardation.

AbstractOBJECTIVE:
To determine more precisely the effect of prophylactic low dose aspirin on intrauterine growth retardation and perinatal mortality.
DESIGN:
Meta-analysis of 13 published randomised clinical trials.
METHODS:
We searched 18 medical databases, including MEDLINE since 1964 and EMBASE since 1974, review articles and the references from each retrieved report to identify all studies evaluating the effect of aspirin in pregnancy and including both intrauterine growth retardation and perinatal mortality as outcome measures.
RESULTS:
Among 13,234 women from 13 studies between 1985 and 1994, aspirin showed a significant reduction in intrauterine growth retardation (IUGR) (OR 0.82; 95% CI 0.72-0.93; P = 0.003) and a nonsignificant reduction in perinatal mortality (OR 0.84; 95% CI 0.66-1.08; P = 0.18). Subgroup analyses revealed that aspirin was effective at lower doses between 50 and 80 mg/day (IUGR: OR 0.87; 95% CI 0.76-0.99; mortality: OR 0.90, 95% CI 0.70-1.16), but that the preventive effect was greater at higher doses between 100 and 150 mg/day (IUGR: OR 0.36, 95% CI 0.22-0.59; mortality: OR 0.40, 95% CI 0.16-0.97) and among women entered before the 17th week of gestation (IUGR: OR 0.35, 95% CI 0.21-0.58; mortality: OR 0.43, 95% CI 0.17-1.06). We did not identify any specific subgroup of women most likely to benefit from aspirin treatment.
CONCLUSION:
The results of this meta-analysis showed that early aspirin treatment reduced the risk of intrauterine growth retardation. Low dose aspirin should not be used routinely in pregnant women until those most likely to benefit from aspirin treatment have been clearly identified.
AuthorsH Leitich, C Egarter, P Husslein, A Kaider, M Schemper
JournalBritish journal of obstetrics and gynaecology (Br J Obstet Gynaecol) Vol. 104 Issue 4 Pg. 450-9 (Apr 1997) ISSN: 0306-5456 [Print] England
PMID9141582 (Publication Type: Journal Article, Meta-Analysis, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-Inflammatory Agents, Non-Steroidal
  • Aspirin
Topics
  • Anti-Inflammatory Agents, Non-Steroidal (administration & dosage)
  • Aspirin (administration & dosage)
  • Female
  • Fetal Growth Retardation (prevention & control)
  • Humans
  • Infant Mortality
  • Infant, Newborn
  • Odds Ratio
  • Pregnancy
  • Prenatal Care
  • Randomized Controlled Trials as Topic
  • Sensitivity and Specificity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: